A practical 2026 guide to LHWCA claims for U.S. dockworkers, longshoremen, ship repairers, and shipbuilders. Covers the situs and status coverage tests, how the LHWCA differs from the Jones Act and state workers' comp, benefit types, the Section 905(b) vessel-negligence claim, the claims and appeals process, and how to choose an attorney.
A practical U.S. guide to refinery and chemical-plant explosion and burn injury lawsuits. Learn why workers' comp alone leaves money on the table, who you can actually sue as a third party (contractors, equipment makers, site owners), OSHA's role, negligence versus gross negligence, how burn damages are calculated, the claim timeline, and how contingency-fee lawyers work.
FIS (Fidelity National Information Services) stock outlook for 2026. A deep look at the core-banking switching-cost moat, the Worldpay separation and capital reshuffle, recurring revenue and buybacks, Fiserv and Global Payments rivalry, and the stagnation-versus-fintech-disruption debate.
A 2026 stock outlook for Ryan Specialty (NYSE: RYAN). How a wholesale excess & surplus (E&S) and specialty insurance broker actually makes money, why the hard market powered its growth, the M&A roll-up model, organic growth and EBITDAC margin, plus rate-softening, integration, leverage and key-person risks.
PVH Corp (PVH) stock outlook for 2026. A deep look at the Calvin Klein and Tommy Hilfiger brand engines, the PVH+ direct-to-consumer transformation, wholesale weakness and European consumer exposure, inventory and tariff risk, and why the stock trades at such a low multiple relative to its brand value.
Carlyle Group (NASDAQ: CG) 2026 stock outlook. A deep look at the private equity, credit and infrastructure segments, fee-related earnings (FRE) versus performance carry, the fundraising cycle, the valuation gap with Blackstone, KKR, Apollo and Ares, plus rate and key-person risk.
Boot Barn (BOOT) 2026 stock analysis: the western and workwear category-killer store model, exclusive-brand margin engine, unit-growth runway, oil-patch and discretionary-consumer exposure, and the expansion-execution risk that defines the stock.
WHR (Whirlpool) 2026 stock outlook. A grounded look at Maytag and KitchenAid brand scale in North America, replacement-demand cash flows, dividend sustainability, housing and rate-cycle exposure, Samsung/LG/Haier low-cost competition, and the balance-sheet debt question.
A.O. Smith (AOS) 2026 stock analysis: the North American water-heater replacement-demand oligopoly cash cow, water treatment growth, the two faces of China and India, steel and tariff risk, and what a Dividend Aristocrat's capital allocation tells investors.
GKOS (Glaukos) 2026 stock outlook. A deep qualitative look at its glaucoma MIGS leadership with iStent, the iDose sustained drug-delivery pivot, the Epioxa corneal-disease pipeline, and the reimbursement, competition, and cash-burn growth-stock risks.
United Therapeutics (UTHR) stock outlook for 2026. A qualitative deep dive into the treprostinil pulmonary hypertension franchise, Tyvaso DPI growth, Liquidia and sotatercept competition, patent-cliff risk, and the long-shot optionality of manufactured organs and xenotransplantation.
Paylocity (PCTY) 2026 stock analysis: mid-market cloud payroll and HCM SaaS, subscription plus client-fund float income, module expansion, real free cash flow, competition from ADP, Paycom, and Workday, employment sensitivity, and valuation risk.
Samjin Pharmaceutical (KOSPI 005500) 2026 stock outlook. A deep look at the steady cash flow from its clopidogrel antithrombotic and Geworin OTC analgesic, the option value of the Magok R&D new-drug pipeline, and the drag from generic drug-pricing cuts and originator competition.
IS Dongseo (KRX: 010780) stock outlook for 2026. A sum-of-the-parts breakdown of the Eileen's Deul housing arm, the INUS ceramics and sanitaryware business, and the environmental engine of waste incineration, landfill, and battery recycling, plus the property-cycle, rate, and PF risks that anchor the valuation.
BH Co. (KOSPI 090460) 2026 stock outlook. A deep, qualitative look at its OLED flexible printed circuit board position in the Apple supply chain, the automotive and EV-battery FPCB diversification push, single-customer concentration, ASP pressure, and won-dollar currency exposure for foreign investors.
Mirae Asset Life (085620) 2026 stock outlook. A deep qualitative look at Korea's variable- and pension-centric asset-management-style life insurer: its fee-income model, IFRS17 CSM and rate sensitivity, the low-growth value-trap risk, and the buyback-and-dividend catalyst that could re-rate the shares.
Contentree JoongAng (036420) 2026 stock analysis: the SLL multi-label drama studio supplying Netflix and global OTT, the Megabox cinema segment, production-cost inflation and hit-driven volatility, the accumulated losses and debt load, and how this Korea-listed content name compares with Studio Dragon and CJ ENM.
Korea Line Corporation (KOSPI: 005880) 2026 stock outlook. A shipping analyst breaks down the long-term contract (COA) dry-bulk and LNG cash floor, SM Group ownership, Baltic Dry Index cycle exposure, debt and bunker-fuel risk, and how it stacks up against Pan Ocean and HMM.
K Car (KRX 381970) stock outlook for 2026. A deep qualitative look at the direct-purchase certified used-car retail model, its scale and trust-brand moat, Hyundai and Kia entering certified pre-owned, the used-car price cycle, rates and discretionary-demand risk, and the metrics that matter.
Seongwoo Hitech (015750) 2026 stock outlook. A deep qualitative look at the Hyundai-Kia captive body-parts model, hot-stamping and giga-steel lightweighting technology, new EV battery-housing revenue, and the risks of single-customer dependence, thin margins, steel costs, and currency swings for the KOSDAQ auto-parts supplier.
Voronoi (KOSDAQ 310210) 2026 stock outlook. A deep look at its brain-penetrant precision kinase oncology platform, the out-licensing royalty and milestone business model, the clinical-binary, cash-burn and dilution risks, Korean biotech peer comparison, and what foreign investors should know about KRW currency exposure.
A 2026 outlook on KCTech (281820, KOSPI), the Korean chip materials and equipment supplier. We dig into its CMP slurry localization moat, the lumpy fab-capex exposure of its cleaning and deposition tools, Chinese slurry competition, customer concentration on Samsung and SK Hynix, and what a foreign investor should watch.
A practical 2026 guide to anesthesia error malpractice claims in the US: what qualifies as negligence, common error types, whether the anesthesiologist, CRNA, or hospital is liable, damages, statute of limitations, and how to choose a lawyer.
A practical 2026 guide to dental malpractice claims in the U.S.: the four elements you must prove, bad outcome vs. negligence, common case types like nerve injury and wrong-tooth extraction, damages, the lawsuit process, choosing a lawyer, fees, and the statute of limitations.